Open House Discount Contracts 2026 - 14 - Lipegfilgrastim
Original notice title
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 14 - Lipegfilgrastim
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
20 / 100
Risk factors
No estimated value or volume is provided, making it impossible to assess potential revenue.
The legal basis is unclear – the notice states it is not a public procurement under EU directives, but still follows an...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Jun 2028
- Supply of Lipegfilgrastim (pharmaceutical product, CPV 33600000) under discount agreements with TK and associated health insurers.
- Nationwide coverage in Germany.
Show full summary
Open House procedure by Techniker Krankenkasse (TK) for discount agreements on Lipegfilgrastim. Eligible pharmaceutical entrepreneurs can conclude contracts at any time during the 24-month term (July 2026 – June 2028). No estimated value or volumes are disclosed. Award criteria are not applied; all eligible participants are accepted. Submission is via email with qualified electronic signature or by post.
Risks
No estimated value or volume is provided, making it impossible to assess potential revenue.
The legal basis is unclear – the notice states it is not a public procurement under EU directives, but still follows an...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur (as per §4 Abs. 18 AMG) for the offered medicinal product.
- Must have a valid marketing authorization in Germany or EEA.
Eligibility
- Must provide self-declaration regarding authorization and reliability (no exclusion grounds).
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open House Discount Contracts 2026 - 14 - Lipegfilgrastim
Discount agreement for the active substance Lipegfilgrastim. Contract term up to 24 months starting 01 July 2026, ending no later than 30 June 2028. Contracts may be concluded at any time during the term.
Location
Duration
Category
Award Criteria
Deadline
Award details
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Lipegfilgrastim zu schließen.
Value note
Show original TED data
Original lot title
Open House Biologika Rabattverträge 2026 - 14 - Lipegfilgrastim
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Lipegfilgrastim zu schließen.
Procurement Details
- Publication date
- 19 May 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 345828-2026
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
20 / 100
Risk factors
No estimated value or volume is provided, making it impossible to assess potential revenue.
The legal basis is unclear – the notice states it is not a public procurement under EU directives, but still follows an...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications